Our results suggest that NR2F2 may play an important role in breast cancer metastasis and thus may be a potential drug target to prevent metastasis in breast cancer with hyperinsulinemia patients or breast cancer with type 2 diabetes patients. The gene discussed is NR2F2; the disease is breast cancer.